Waldenström macroglobulinemia presenting as cryoglobulinemic type II membranoproliferative glomerulonephritis

[1]  K. Amann,et al.  Membranoproliferative glomerulonephritis complicating Waldenström’s macroglobulinemia , 2012, BMC Nephrology.

[2]  F. Combarnous,et al.  Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report , 2012, Journal of Medical Case Reports.

[3]  So young Lee,et al.  Waldenstrom Macroglobulinemia with CD5+ Expression Presented as Cryoglobulinemic Glomerulonephropathy: A Case Report , 2011, Journal of Korean medical science.

[4]  Richard J. H. Smith,et al.  Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[5]  F. Roudot-thoraval,et al.  Clinical and Morphologic Spectrum of Renal Involvement in Patients With Mixed Cryoglobulinemia Without Evidence of Hepatitis C Virus Infection , 2009, Medicine.

[6]  D. de Jong,et al.  Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas , 2009, Journal of hematopathology.

[7]  A. Hanbali,et al.  Incidence of hepatitis B reactivation following Rituximab therapy , 2009, American journal of hematology.

[8]  E. Kimby,et al.  Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Benjamin Deroure,et al.  Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[10]  K. Moon,et al.  Waldenström's macroglobulinaemia presenting as reticulate purpura and bullae in a patient with hepatitis B virus infection , 2001, Clinical and experimental dermatology.